Ashish Joshi1, Sushil Falodia1, Naveen Kumar2, Pawan Gupta3, P C Khatri3. 1. Department of Gastroenterology, Sardar Patel Medical College, Bikaner, 334 001, India. 2. Department of General Medicine, Sardar Patel Medical College, Bikaner, 334 001, India. naveengoudamv@gmail.com. 3. Department of Pediatrics, Sardar Patel Medical College, Bikaner, 334 001, India.
Abstract
BACKGROUND: Liver involvement in celiac disease (CD) is classified into autoimmune and cryptogenic. The association between CD and autoimmune liver diseases like autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis is well-established; however, the data on patients with cryptogenic cirrhosis, particularly from India, are scanty. So we did this study to find the prevalence of CD in patients with cryptogenic cirrhosis. METHODS: This was a prospective observational study, involving children of less than 18 years old attending Pediatric and Gastroenterology clinic with a diagnosis of cryptogenic cirrhosis. The patients were evaluated for CD and divided into two groups: chronic liver disease (CLD) with CD, and CLD without CD. Both the groups were followed up for 6 months. CLD with CD group was treated with gluten-free-diet (GFD) and CLD without CD group was followed up without any specific intervention except standard care of CLD. RESULTS: Out of 84 patients, 11 (13.1%) were diagnosed as CLD with CD. There was an improvement in hemoglobin levels, liver function tests, and Child-Pugh score after initiation of GFD in CLD with CD group. CONCLUSION: The prevalence of CD in cryptogenic cirrhosis was 13.1%. Screening for CD is recommended for cryptogenic cirrhosis. Hepatic functions improve with a GFD in CD patients with cirrhosis.
BACKGROUND: Liver involvement in celiac disease (CD) is classified into autoimmune and cryptogenic. The association between CD and autoimmune liver diseases like autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis is well-established; however, the data on patients with cryptogenic cirrhosis, particularly from India, are scanty. So we did this study to find the prevalence of CD in patients with cryptogenic cirrhosis. METHODS: This was a prospective observational study, involving children of less than 18 years old attending Pediatric and Gastroenterology clinic with a diagnosis of cryptogenic cirrhosis. The patients were evaluated for CD and divided into two groups: chronic liver disease (CLD) with CD, and CLD without CD. Both the groups were followed up for 6 months. CLD with CD group was treated with gluten-free-diet (GFD) and CLD without CD group was followed up without any specific intervention except standard care of CLD. RESULTS: Out of 84 patients, 11 (13.1%) were diagnosed as CLD with CD. There was an improvement in hemoglobin levels, liver function tests, and Child-Pugh score after initiation of GFD in CLD with CD group. CONCLUSION: The prevalence of CD in cryptogenic cirrhosis was 13.1%. Screening for CD is recommended for cryptogenic cirrhosis. Hepatic functions improve with a GFD in CDpatients with cirrhosis.
Authors: M Bonamico; G Pitzalis; F Culasso; A Vania; S Monti; C Benedetti; P Mariani; A Signoretti Journal: Minerva Pediatr Date: 1986-11-15 Impact factor: 1.312
Authors: Rakhi Maiwall; Ashish Goel; Anna B Pulimood; Sudhir Babji; J Sophia; Chaya Prasad; K A Balasubramanian; Banumathi Ramakrishna; Susy Kurian; G John Fletcher; Priya Abraham; Gagandeep Kang; B S Ramakrishna; Elwyn Elias; C E Eapen Journal: Indian J Gastroenterol Date: 2014-09-18
Authors: M T Bardella; M Vecchi; D Conte; E Del Ninno; M Fraquelli; S Pacchetti; E Minola; M Landoni; B M Cesana; R De Franchis Journal: Hepatology Date: 1999-03 Impact factor: 17.425
Authors: U Volta; L De Franceschi; N Molinaro; F Cassani; L Muratori; M Lenzi; F B Bianchi; A J Czaja Journal: Dig Dis Sci Date: 1998-10 Impact factor: 3.199